Three public companies rolled into one, an enterprise value of $31 billion, a strong balance sheet, over $20 billion in an investment-management business, and operating in 21 countries around the world, Prologis is the company Hamid Moghadam, winner of the Ernst & Young U.S. Entrepreneur of the Year (2014) built since he founded AMB Property Corp in 1983 with a $50,000 line of credit from a regional bank. And it�� a stock that�� worth a look by investors, as well, having performed nicely since the last several years, but with plenty of room to run ahead.
As the real-estate crisis unfolded in 2008, Mr. Moghadam acted boldly and intelligently, taking advantage of opportunities around the world and eventually merging AMB with ProLogis (PLD) �in 2011 to create the current, a company who�� stock, since the bottom of the crisis in 2009, has outperformed the S&P 500.
Top 10 Life Sciences Stocks To Invest In 2015: Ishares Msci Australia Inc (EWA)
iShares MSCI Australia Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Australian market, as measured by the MSCI Australia Index (the Index). The Index seeks to measure the performance of the Australian equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Chad Fraser]
Another option is to buy units of an Australian exchange traded fund (ETF) like the iShares MSCI Australia Index Fund (NYSE: EWA), one of the investments we cover in Australian Edge’s How They Rate universe, which keeps over 100 Australian companies and other investments under continuous review.
Top 5 Regional Bank Stocks To Own For 2014: Phillips-Van Heusen Corporation(PVH)
PVH Corp. designs and markets branded dress shirts, neckwear, sportswear, footwear, and other related products worldwide. The company?s Calvin Klein Licensing segment licenses Calvin Klein Collection, ck Calvin Klein, and Calvin Klein brands for sportswear, jeanswear, underwear, fragrances, eyewear, men?s tailored clothing, women?s suits and dresses, hosiery, socks, footwear, swimwear, jewelry, watches, outerwear, handbags, leather goods, home furnishings, and accessories; and to operate retail stores. Its Wholesale Dress Furnishings segment markets dress shirts and neckwear principally under the ARROW, Calvin Klein, ck Calvin Klein, Calvin Klein Collection, IZOD, Eagle, Sean John, Donald J. Trump Signature Collection, Kenneth Cole New York, Kenneth Cole Reaction, JOE Joseph Abboud, DKNY, Tommy Hilfiger, Elie Tahari, J. Garcia, and MICHAEL Michael Kors brands. The company?s Wholesale Sportswear and Related Products segment offers sportswear, including men?s knit and w oven sport shirts, sweaters, bottoms, swimwear, boxers, and outerwear principally under the IZOD, Van Heusen, ARROW, Geoffrey Beene, Timberland, and Calvin Klein brands; and women?s sportswear, including knit and woven sport shirts, sweaters, bottoms, and outerwear under the IZOD brand. Its Retail Apparel and Related Products segment provides men?s dress shirts; neckwear and underwear; men?s and women?s suit separates; men?s and women?s sportswear, including woven and knit shirts, sweaters, bottoms, and outerwear; men?s and women?s accessories; sportswear; and men?s fragrance. The company?s Retail Footwear and Related Products segment offers casual and dress shoes for men, women, and children; and apparel and accessories. The company was formerly known as Phillips-Van Heusen Corporation and changed its name to PVH Corp. in June, 2011. The company was founded in 1881 and is headquartered in New York, New York.
Advisors' Opinion:- [By Mike Deane]
PVH Corp. (PVH) announced its Q2 earnings after the bell on Monday, posting non-GAAP figures that showed an increase from last year’s Q2 EPS and revenues.
The New York, NY-based clothing company announced non-GAAP EPS of $1.39, which was up from last year’s Q2 EPS figure of $1.28, and above the analysts’ estimate of $1.37. GAAP results came in at a 20 cent loss per share due to acquisition, integration and restructuring costs associated with the company’s acquisition of Warnaco Group.
On the revenues front, PVH posted quarterly results of $1.965 billion, a 47% increase from last year’s Q2 figure, and above the analysts’ estimate of $1.89 billion. The uptick in revenues was primarily due to the revenues from the newly acquired Warnaco.
PVH shares were up $2.14, or 1.62%, at the end of trading on Monday. The company’s stock is up 16.25% YTD.
- [By Holly LaFon] orp. designs and markets branded dress shirts, neckwear, sportswear, footwear and other related products. Cooperman bought 352,300 shares of PVH Corp. in the fourth quarter at an average of $67 per share.
PVH has a market cap of $5.35 billion; its shares were traded at around $81.3 with a P/E ratio of 15.5 and P/S ratio of 1.3. The dividend yield of PVH Corp. stocks is 0.2%. PVH Corp. had an annual average earnings growth of 9.3% over the past 10 years.
PVH recently drastically increased its revenue, from $2.4 billion in 2010 to $4.6 billion in 2011, helped by its 2010 acquisition of Tommy Hilfiger. Earnings, however, were lower, falling from $162 million in 2010 to $53.8 million in 2011, as the cost of goods sold was increased significantly as well. The company expects earnings growth for 2012 to occur in the second half of the year as the first half�� margins will be pressured from higher product costs over last year.
The company recently raised its 2011 earnings per share guidance to a range of $5.28 to $5.30 from the previously expected range of $5.23 to $5.25. The raised guidance came due to strong performance in its Calvin Klein and Tommy Hilfiger businesses. Year over year fourth quarter sales are expected to increase by 15% in the Calvin Klein business, 12% in the Tommy Hilfiger North America business, 12% in the Tommy Hilfiger International business and 4% in the Heritage Brands business.
PVH Corp. had about $782 million in cash on its balance sheet at the end of the third quarter, and approximately $3.1 billion in long-term liabilities and debt.
Medco Health Solutions Inc. (MHS)
Cooperman also bought shares of Medco, the company merging with his largest new holding, Express Scripts. Under their agreement, Medco shareholders will receive $71.36 per share in cash and stock, or $2.9 billion. Medco shareholders will receive $28.80 in cash and $0.81 shares for each Medco share they own upon closing of the transaction.
- [By Rick Munarriz]
Wednesday
PVH (NYSE: PVH ) dresses up for its fresh financials on Wednesday. The company behind Calvin Klein, Tommy Hilfiger, and other popular apparel brands is expected to earn $1.35 a share in its latest quarter, just ahead of the $1.30 it posted a year earlier. PVH has landed ahead of analyst profit targets in each quarter over the past year, so don't be surprised if it earns more than the $1.35 the market is settling for this time around. - [By Amal Singh]
PVH (NYSE: PVH ) is one of the world's largest apparel companies, and controls several different brands such as Calvin Klein, Tommy Hilfiger, and Heritage. It is also the world's largest shirt and neckwear company, and markets its products under different brands such as Arrow, Van Heusen, and Bass. Driven by the strength of its iconic brands and good products, the company has consistently done well in the past few years, as seen in the chart below.
Top 5 Regional Bank Stocks To Own For 2014: BG Group PLC (BRGXF.PK)
BG Group plc (BG Group) is a natural gas company. The Company is engaged in the exploration, development and production of natural gas and oil. It operates in three business segments: Exploration and Production (E&P), Liquefied Natural Gas (LNG) and Transmission and Distribution (T&D). Effective January 1, 2012, the Company was managed across three regions: Americas and Europe; Africa, Central and South Asia, and Australia and East Asia, supported by Global Energy Marketing and Shipping (GEMS) and BG Advance. The Company has interests in 25 countries on five continents. During the year ended December 31, 2011, the Company acquired an interest in, and operatorship of, offshore blocks L10A (BG Group 40%) and L10B (BG Group 45%) in Kenya. During 2011, the Company acquired additional Marcellus shale properties in partnership with EXCO Resources, Inc. (EXCO). In June 2013, BG Group PLC announced that it has completed the sale of its 65.12% holding in Gujarat Gas Company Limited (GGCL). Advisors' Opinion:- [By Heather Ingrassia]
On Thursday, August 15, GasLog (GLOG) announced that it had ordered two new 174K cbm Tri-Fuel Diesel Electric LNG carriers from Samsung Heavy Industries. These carriers are expected to be delivered in 2016 which is the same year the company will begin seven-year charters with BG Group (BRGYY.PK) (BRGXF.PK).
Top 5 Regional Bank Stocks To Own For 2014: NovaBay Pharmaceuticals Inc. (NBY)
NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the development of various product candidates for the therapeutic needs of the anti-infective market. Its products include Aganocide compounds comprising NVC-422 that are synthetic molecules for the treatment of impetigo and adenoviral conjunctivitis, as well as for reducing the incidence of urinary catheter blockage and encrustation, and the associated urinary tract infections. The company is also involved in developing NeutroPhase, a solution for cleansing and debriding wounds. It has collaboration and license agreement with Galderma S.A. to develop and commercialize its Aganocide compounds, which covers acne, impetigo, and other dermatological conditions. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.
Advisors' Opinion:- [By CRWE]
NovaBay(r) Pharmaceuticals, Inc. (Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide(r) compounds for the local non-systemic treatment and prevention of infections, reported that Tom Paulson, Chief Financial Officer, will present at the Rodman & Renshaw 14th Annual Healthcare Conference held September 9-11, 2012, in New York, NY.
No comments:
Post a Comment